Current/ Expected Orderbook/ Pending Orders?

Current order book stands at approximately INR 2,300 crores. The order book has shown continuous growth for the third consecutive quarter. Order intake in H1 FY26 crossed INR 1,000 crores, reflecting 130% YoY growth. Book-to-bill ratio for the quarter was 1.6; expected to sustain around 1.4 to 1.5 for the full year. Over 10% of the current order book is from build-to-spec (B2S) projects, which are long-term and design-led. Most orders have a duration of 18 to 24 months; B2S orders have a longer gestation but extend up to 9-20 years in some cases. Approximately 50% of Q1 order intake is expecte

Any current/future new fundraising through debt or equity?

There is no mention of any current or planned new fundraising through debt or equity in the document. The company has nearly exhausted the funds raised during its IPO (93% utilization) as of the third anniversary after the IPO. Despite utilizing IPO funds, Cyient DLM Limited maintains a healthy cash balance and is comfortably placed to fund any growth internally. No indications or announcements regarding additional capital raises, either through debt or equity, were disclosed during this quarter or in future guidance.

Any current/future capex/capital investment/strategic investment?

Cyient DLM has nearly exhausted IPO funds raised three years ago, with about 93% utilized so far. The remaining capital expenditure related to the land acquisition in Mysore for building their own factory is still to be spent. The company is well-positioned with healthy cash reserves to fund future growth opportunities. Ongoing investments continue in the Build-to-Spec (B2S) business and product-led IP development. The company is also pursuing inorganic growth opportunities via acquisitions focused on North America and Europe to expand client proximity and enter new industries such as rail and

Future growth expectations in sales/revenue/volumes?

Q4 FY26 expected to see year-on-year growth, driven more by Industrial side than Defence. Build to Spec (B2S) business is a key focus area with healthy growth and sales pipeline; though mass production primarily starts FY28 onwards, some small orders already in production. Order book refreshed with better margin revenue, supporting confidence in maintaining and growing double-digit EBITDA margins. Long-term B2S contracts (some up to 20 years) provide business stability and growth visibility. Q1 and Q2 have shown good growth momentum expected to accelerate in the rest of FY26 and into F

Future growth expectations in earnings/operating earnings/profits/EPS?

Confidence in maintaining and growing double-digit EBITDA margins in the foreseeable future, with current margins just above 10%. Order book refreshed with higher-margin revenue, indicating quality growth and margin expansion as business scales. Strong growth expected in Q1 and Q2, with acceleration anticipated for the rest of the year. Build-to-spec (B2S) business, with long-term contracts (some up to 20 years), provides stable and sustainable revenue streams supporting margin expansion. Early-stage product development engagements improving value proposition, supply chain control, and

IN US

Sale is live|00:00:00left today

Cyient DLM LtdQ3 FY25Aerospace & Defense

Cyient DLM Ltd Q3 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹462P/E: 45.1Market Cap: ₹3.3K CrSector: Aerospace & Defense

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Order

Yes

Capex

Yes

2 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→Q4 FY26 expected to see year-on-year growth, driven more by Industrial side than Defence.
→Build to Spec (B2S) business is a key focus area with healthy growth and sales pipeline; though mass production primarily starts FY28 onwards, some small orders already in production.
→Order book refreshed with better margin revenue, supporting confidence in maintaining and growing double-digit EBITDA margins.
→Long-term B2S contracts (some up to 20 years) provide business stability and growth visibility.
→Q1 and Q2 have shown good growth momentum expected to accelerate in the rest of FY26 and into FY27.
→Diversification efforts targeted at non-A&D sectors including industrial, automotive (especially EV infrastructure), and medical, aiming to broaden customer base.
→Strong domestic (India) market growth alongside exports, with exports expected to remain highest contributor.
→Overall, momentum points to a revival in year-over-year growth starting H2 FY26 and continuing into FY27.

Margin guidance

Category 3

→Confidence in maintaining and growing double-digit EBITDA margins in the foreseeable future, with current margins just above 10%.
→Order book refreshed with higher-margin revenue, indicating quality growth and margin expansion as business scales.
→Strong growth expected in Q1 and Q2, with acceleration anticipated for the rest of the year.
→Build-to-spec (B2S) business, with long-term contracts (some up to 20 years), provides stable and sustainable revenue streams supporting margin expansion.
→Early-stage product development engagements improving value proposition, supply chain control, and margins.
→Order intake momentum strong with a book-to-bill ratio above 1.4-1.6, signaling growth in revenues ahead.
→Gradual increase in built-to-spec revenue expected, especially in FY27, supporting margin expansion and profitability.
→No formal FY27 guidance but early indications suggest a resumption of growth trajectory and sustained profitability improvement.

3 more insights locked — sign up free to unlock

Fundraise plans

→There is no mention of any current or planned new fundraising through debt or equity in the document.
→The company has nearly exhausted the funds raised during its IPO (93% utilization) as of the third anniversary after the IPO.
→Despite utilizing IPO funds, Cyient DLM Limited maintains a healthy cash balance and is comfortably placed to fund any growth internally.
→No indications or announcements regarding additional capital raises, either through debt or equity, were disclosed during this quarter or in future guidance.

Order book

Yes

→Current order book stands at approximately INR 2,300 crores.
→The order book has shown continuous growth for the third consecutive quarter.
→Order intake in H1 FY26 crossed INR 1,000 crores, reflecting 130% YoY growth.
→Book-to-bill ratio for the quarter was 1.6; expected to sustain around 1.4 to 1.5 for the full year.
→Over 10% of the current order book is from build-to-spec (B2S) projects, which are long-term and design-led.
→Most orders have a duration of 18 to 24 months; B2S orders have a longer gestation but extend up to 9-20 years in some cases.
→Approximately 50% of Q1 order intake is expected to be executable in H2 FY26.
→New orders include significant wins in automotive and industrial sectors, including electric vehicle infrastructure.
→Management expresses confidence about continued order book growth and robust execution throughout FY26 and beyond.

Capex plans

Yes

→Cyient DLM has nearly exhausted IPO funds raised three years ago, with about 93% utilized so far.
→The remaining capital expenditure related to the land acquisition in Mysore for building their own factory is still to be spent.
→The company is well-positioned with healthy cash reserves to fund future growth opportunities.
→Ongoing investments continue in the Build-to-Spec (B2S) business and product-led IP development.
→The company is also pursuing inorganic growth opportunities via acquisitions focused on North America and Europe to expand client proximity and enter new industries such as rail and automotive.
→Strategic investments are aimed at strengthening existing customer relationships, focusing on domestic market growth, and transforming into a product/IP-led organization.

How does Cyient DLM Ltd rank vs peers in Aerospace & Defense?

Pro feature

1Cyient DLM Ltd

Rev 3Mar 3

See full Aerospace & Defense sector rankings

Want more stocks like Cyient DLM Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio